Skip to main content Accessibility help
×
Home
Instructions for authors
Editorial Aims and Scope

The Journal welcomes submission of manuscripts that evaluate health technologies to support health policy or practice decisions: Health Technology Assessments (HTAs), discussion of methods used in HTA, or related policy pieces. Health technologies encompass medicines, devices, diagnostic tools, or interventional procedures including mobile health technologies and telemedicine. We publish secondary research, for example systematic literature reviews, modeling studies, or economic evaluations, while primary research (such as diagnostic or treatment studies) is more suitable for relevant specialty journals. See the Manuscript Types table below. We do not publish papers on healthcare education, management or IT systems.

The evidence for secondary studies commonly originates from published comparative or non-comparative studies but may also include real world data or evidence. HTAs also incorporates areas relating to ethics, organizational issues, and patient and citizen involvement. Where relevant, manuscripts could include a paragraph on the policy implications of the findings.

Manuscripts are screened by the Editor-in-Chief and Deputy Editors and those that are deemed appropriate for the journal proceed to an international review process, which usually is completed within 10 weeks. Manuscripts may undergo more than one round of review. On occasion, the original reviewers may not be available, in which case, a new reviewer may be invited. Accepted manuscripts will be copy edited and published first on FirstView and later as part of an issue. The timeframe from acceptance to FirstView is usually within 6 weeks. Manuscripts must be in English using American spelling. Spelling, capitalization, and punctuation should conform to the 17th Edition of The Chicago Manual of Style (University of Chicago Press). Refer to Preparation of Manuscript below for more details.

While papers are under review, all queries should be directed to the editorial office at IJTAHC@cambridge.org. Any queries sent to the Editorial Board will be forwarded to the editorial office to be answered.

Format-Minimal Submission

IJTAHC has now introduced format-minimal submissions for original submissions only. We ask that authors adhere to the following guidelines:

  1. The manuscript must include line numbering, be double spaced, and be presented in an easily readable layout.
  2. A conflict of interest statement must be present in the manuscript (if there are no conflicts, this must be clearly stated).
  3. References must be numbered and cited numerically in the text.
  4. The total combined number of figures and tables should not exceed the limits for the specific article types (this is 5 for most article types and 2 for Perspectives).
  5. The total manuscript length should not significantly exceed the word limits for the article type (around 4000 words for most article types, 2000 words for perspectives).
  6. Manuscript Submission and Review

    All manuscript submissions to the International Journal of Technology Assessment in Health Care must be made electronically via ScholarOne Manuscripts at https://mc.manuscriptcentral.com/thc. Authors should follow the style and formatting outlined in the Manuscript Types table and Preparation of Manuscript section below.

    Please follow the detailed instructions on the website to avoid delays. The authors are asked to provide contact information and they may suggest reviewers. The website automatically acknowledges receipt of the manuscript and provides a manuscript reference number. Every effort will be made to provide the review promptly. Correspondence must quote the manuscript reference number and should be sent by email to the Editorial Office at IJTAHC@cambridge.org.

    Manuscript Types

    The Journal accepts the following types of manuscripts:

    Manuscript type Suggested length * Abstract** Max. Refs Tables/figures Additional comments
    Editorial 1,000–1,500 words No 10 No Short piece related to content in that issue without an abstract, invited by the Editor-in-Chief (Associate Professor Wendy Babidge, wendy.babidge@adam.com.au).
    Perspective 2,000 words maximum 150 words, unstructured 25 Maximum 2 total tables and figures (combined) An opinion piece relating to ideas in the field (currently held or new), or a historical account of interest to the readership or useful for learning for young researchers in the field. Perspectives are usually reviewed internally by the editorial team and editorial board but may be sent for external peer review at the discretion of the editor.
    Commentary 4,000 words maximum 250 words maximum, unstructured 25 Maximum 5 total tables and figures (combined) Used where the manuscript does not fit other types (Methods Assessment, Policy), for example reports from HTAi working groups. Commentaries will undergo external peer review.
    Method 4,000 words maximum 250 words maximum, structured 25 Maximum 5 total tables and figures (combined) Method manuscripts will undergo external peer review.
    Assessment 4,000 words maximum 250 words maximum, structured25*** Maximum 5 total tables and figures (combined) Assessment manuscripts will undergo external peer review.
    Health Technology Assessments (HTAs), often involve a systematic review; and they include topics such as (but are not limited to) economic evaluations, hospital-based HTAs, and patient and citizen involvement Usually the assessments are secondary and not primary research studies, although use of real world evidence to complement published evidence is acceptable.
    Policy 4,000 words maximum 250 words maximum, structured 25 Maximum 5 total tables and figures (combined) Policy manuscripts will undergo external peer review.
    HTAi Guidance 4,000 words maximum 250 words maximum, unstructured 25 Maximum 5 total tables and figures (combined) The International Journal of Technology Assessment in Health Care (IJTAHC) publishes reports on guidance developed by HTAi or other task forces or special interest groups. These reports provide guidance for best practices across a variety of research areas, including methods related to articles relevant to the scope of the IJTAHC. These include health technology assessment, comparative effectiveness research, real-world evidence, economic evaluation, modeling, ethics, patient and citizen involvement and the use of outcomes research in decision making.
    Letter 500 words maximum No 10 No A response to a published article. This will not be peer reviewed but will be assessed by the editorial team.
    In Memoriam 500 words maximum No 5 None Short account of a key person in the HTA field who has recently passed away. Will undergo internal review.

    * Maximum word count excludes references, tables, figures, and any acknowledgments or disclosures. Manuscripts must comply to suggested lengths, but editors may sometimes decide to allow exceptions. Please contact the Editor-in-Chief (wendy.babidge@adam.com.au) or the Managing Editor (IJTAHC@cambridge.org) if you seek an exception.
    ** The headings for structured abstracts should be Objectives, Methods, Results, and Conclusions.
    *** More references are allowed for systematic reviews, ideally less than around 50.

    Virtual Special Issues

    The Journal can publish groups of related articles on the same theme, forming a Virtual Special Issue. Manuscripts for theme issues may be Commentaries or other article types.

    Virtual Special Issues can be suggested by providing a list of proposed topics (titles and authors) to the Editor-in-Chief, Associate Professor Wendy Babidge (wendy.babidge@adam.com.au). Virtual Special Issue topics must be accepted by the Editor-in-Chief before authors are notified to submit. The proposal must also indicate the names of 2 to 3 Virtual Special Issue Editors. Submissions will undergo external peer review coordinated by the Virtual Special Issue Editors, and will usually include an Editorial, written by the Virtual Special Issue Editors.

    Preparation of Manuscript

    The manuscript, including all references, must be provided in Word or RTF format, double spaced with line numbering, on 8½ × 11 inch or A4 page sizes, with at least 1-inch (2.54 cm) margins. Please see guidelines for specific manuscript types above for further guidance. Manuscripts should be arranged as follows:

    1. Main Document (consisting of one file):
      1. Title page with the full title, running title, and full author names with affiliations (including contact information for the Corresponding Author)
      2. Abstract and keywords
      3. Acknowledgments, including sources of funding
      4. Conflict of Interest statement
      5. Text
      6. References
      7. Tables
      8. Figure captions
    2. Figures
      Each figure must be uploaded as a separate file.
    3. Supplementary Files
      Each supplementary file must be numbered (Supplementary file 1, 2 etc.), referred to in the text, and have a title.
    4. Completed Conflict of Interest forms for each author
    5. For revised manuscripts, a completed Copyright Transfer Form

    Cover Letter. The cover letter must attest that 1) each author contributed to the conception and design or analysis and interpretation of data and the writing of the paper (ICMJE rules); 2) each has approved the version being submitted; and 3) the content has not been published nor is being considered for publication elsewhere.

    Title Page. The title page should include the full title (20 words maximum) in all caps, running title (50 characters maximum), and full author names with professional degrees and affiliations. Include a complete mailing address, telephone number, and email address for the Corresponding Author.

    Abstract and Keywords. Most manuscript types should include a 100- to 250-word abstract, placed on a separate page without a heading, summarizing the objectives of the study or analysis, the major arguments and/or results, and conclusions/recommendations. See information on manuscript types above for further guidance. Three to five keywords, using terms from the Medical Subject Headings from Index Medicus, should follow the abstract.

    Acknowledgements and Sources of Funding. Authors must include a Funding Statement in their manuscript. Within this statement please provide details of the sources of financial support for all authors, including grant numbers, for example: “Funding Statement: This work was supported by the Medical Research Council (grant number XXXXXXX)”.

    Grants held by different authors should be identified as belonging to individual authors by the authors’ initials, for example: “Funding Statement: This work was supported by the Wellcome Trust (AB, grant numbers XXXX, YYYY), (CD, grant number ZZZZ); the Natural Environment Research Council (EF, grant number FFFF); and the National Institutes of Health (AB, grant number GGGG), (EF, grant number HHHH).” Where no specific funding has been provided for research, you should include the following statement:

    “Funding Statement: This research received no specific grant from any funding agency, commercial or not-for-profit sectors.”

    Text. Manuscripts must be in English using American spelling. Spelling, capitalization, and punctuation should conform to the 17th Edition of The Chicago Manual of Style (University of Chicago Press). Refer to recent articles as a guideline when preparing your manuscript. The Journal does not accept footnotes or appendices.

    Acronyms should be clearly spelled out on first use. The use of product trade names should be avoided; generic names should be used except where discussion of proprietary brands is essential to the manuscript. Spell out “percent” rather than using the % symbol except in Tables/Figures. Authors may use their local currency but should also include a conversion to either USD or EUR in brackets.

    Numerals should be spelled out for numbers up to ninety-nine (forty reports, ninety-nine patients) and numerals should be used for numbers 100 and greater (100 patients, 125 countries) However, with units of measure, numerals are always used (15 sec, 2 weeks, 15 ml, 99 years). However, within any one sentence, if >100 of an entity is stated and then <100 of that same entity is also stated, numerals are used for both instances. For example, “...200 questionnaires were received, but only 50 questionnaires met criteria for inclusion in the study.”

    References. The references must be arranged according to ICMJE Uniform Requirements for Manuscripts (URM): numbered consecutively in order of appearance in the text, identified by Arabic numerals. Bibliographic citations in the text should be indicated by Arabic numerals in parentheses. When authors are mentioned in the text, the citation number should immediately follow the name(s) as follows:

    "Jones and Smith (7) maintained that..."

    Please do not use auto-numbering in the reference list. If a work has more than six authors, the first six authors should be listed, followed by et al. If a work has five or fewer authors, include all author names. Abbreviate journal titles according to the listing in the current Index Medicus. Title abbreviations should be italic and end in a period. Capitalize the first word that follows a colon in journal article titles, book chapter titles, and book titles. Do not include month or issue numbers for journals with consecutively numbered volumes. An Endnote style for the ICMJE Uniform Requirements is available here, however as neither Cambridge University Press nor the Journal are responsible for maintaining or updating this file, accuracy of references should always be checked by authors. Examples follow below:

    Book:

    1. Jones AB, Smith JK. Computer diagnosis and results. New York: Penta Publishers; 2011

    Journal:

    1. Jones AB, Smith JK. The relationship between health needs, the hospital, and the patient. J Chron Dis. 2012;49:310-2.
    2. Garattini L, De Compadri P, Clemente R, Cornago D. Economic evaluations in Italy: A review of the literature. Int J Technol Assess Health Care. 2003;19:685-737.

    Article in edited work:

    1. Jones AB, Smith JK. The diagnostic process. In: Brown R, Wilson T, editors. New technology and its medical consequences, vol. 1. New York: Apple Publishers; 2013. p. 101-34.

    Online sources:

    1. European Network for Health Technology Assessment (EUnetHTA) [Internet] Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation v1.4. c2015 [cited 2016 Aug 12]. Available from: http://www.eunethta.eu/sites/5...

    In the reference list, do not include material that has been submitted for publication but has not yet been accepted. This material, with its date, should be noted in the text as "unpublished data" as follows:

    Unpublished data:

    "Similar findings have been noted by LW Smith (unpublished data, 2013)."

    Tables. Tables should be numbered consecutively. All tables must be cited in the text and have an explanatory caption/legend. All abbreviations used in each table must be defined underneath, even if the abbreviations have been defined previously in the text or other Tables. Tables must be submitted in Word or RTF. Tables may be included in the Main Document file after References (not inside text) or uploaded separately.

    Figure Captions. Include a list of figure captions (but not the figures themselves) in the Main Document file, after any tables.

    Figures. Figures should be numbered consecutively and have a Title after the number. All figures must be cited in the text and must have an explanatory caption/legend. Abbreviations in figures should be avoided, except in the case of acronyms already used in the text. All abbreviations used in each figure must be defined in the caption, even if the abbreviations have been defined previously in the text.

    Each figure must be uploaded separately in tif, jpg, or eps format. The figure captions should be included at the end of the Main Document file and not in the individual figure files.

    For detailed figure formatting recommendations, please refer to the Cambridge Journals Artwork Guide.

    Supplementary Files. Tables and figures exceeding the limits given in the Manuscript Types table above may be submitted as Supplementary files and will be accessible through a link in the published article.

    Supplementary tables and figures should be numbered separately from the tables and figures, beginning with Supplementary Table 1 and Supplementary Figure 1.

    Please note that the Typesetters will not amend Supplementary files in any way before publishing. Authors should ensure that Supplementary files appear exactly as intended when submitted. Please ensure that captions are included in supplementary material and that they are sufficient to allow the files to be understood without the main text.

    Conflicts of interest. Authors should include a Conflicts of Interest declaration in their manuscript. Conflicts of Interest are situations that could be perceived to exert an undue influence on an author’s presentation of their work. They may include, but are not limited to, financial, professional, contractual or personal relationships or situations. Conflicts of Interest do not necessarily mean that an author’s work has been compromised. Authors should declare any real or perceived Conflicts of Interest in order to be transparent about the context of their work. If the manuscript has multiple authors, the author submitting the manuscript must include Conflicts of Interest declarations relevant to all contributing authors.

    Example wording for your Conflicts of Interest declaration is as follows: “Conflicts of Interest: Author A is employed at company B. Author C owns shares in company D, is on the Board of company E and is a member of organisation F. Author G has received grants from company H.” If no Conflicts of Interest exist, your declaration should state “Conflicts of Interest: None”.

    All authors must disclose any financial arrangements with companies whose products are discussed in the paper or their competitors; such information will not be revealed to reviewers but may be included in a suitable format in the final publication if the manuscript is accepted. Please find the Conflict of Interest Form here. These forms should be uploaded to ScholarOne with the submitted manuscript.

    Ethical standards

    As relevant to the content of the paper, the manuscript should attest to the fact that any research with human or animal subjects conforms to the legal and ethical standards of the country in which it was performed.

    Where research involves human and/or animal experimentation, the following statements should be included (as applicable): "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2013." and "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals."

    Author Language Services

    Cambridge University Press recommends that authors have their manuscripts checked by an English language native speaker before submission; this will ensure that submissions are judged at peer review exclusively on academic merit. We list a number of third-party services specializing in language editing and/or translation, and suggest that authors contact as appropriate. Use of any of these services is voluntary, and at the author's own expense.

    Permissions

    Authors are responsible for obtaining written permission to publish material for which they do not own the copyright.

    Licence to Publish / Open Access

    IJTAHC is a hybrid Open Access journal. Our copyright forms allow “green” Open Access Archiving (for instance, posting the Accepted Manuscript in an Institutional Repository or on a personal webpage). Authors can also choose to publish “gold” Open Access (making articles freely available for non-commercial use). Please be aware that Gold Open Access entails an Article Processing Charge (APC) — please find information here for up to date information on APCs.

    For complete information on Cambridge's Open Access policies please visit here.

    The policy of the International Journal of Technology Assessment in Health Care is that authors (or in some cases their employers) retain copyright and grant Cambridge University Press a licence to publish their work. In the case of gold open access articles this is a non-exclusive licence. If your manuscript is accepted you will soon afterwards hear from our digital licensing partner Ironclad in order to complete your licensing agreement for publication via email. Your manuscript will not enter our post-acceptance workflow until we have received the signed licence. Please find further information on the process here.

    For open access articles, the agreement also sets out the Creative Commons licence under which the article is made available to end users: a fundamental principle of open access is that content should not simply be accessible but should also be freely re-usable. Articles will be published under a Creative Commons Attribution license (CC-BY) by default. This means that the article is freely available to read, copy and redistribute, and can also be adapted (users can “remix, transform, and build upon” the work) for any commercial or non-commercial purpose, as long as proper attribution is given. Authors can, in the publishing agreement form, choose a different kind of Creative Commons license (including those prohibiting non-commercial and derivative use) if they prefer.

    Copyediting and Proofreading

    The publishers reserve the right to copyedit and proofread all accepted articles. Page proofs will be sent to the lead author for final review.

    ORCID

    International Journal of Technology Assessment in Health Care now requires that all corresponding authors identify themselves using their ORCID iD when submitting a manuscript to the journal. ORCID provides a unique identifier for researchers and, through integration in key research workflows such as manuscript submission and grant applications, provides the following benefits:

    • Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you’ve authored.
    • Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
    • Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.

    If you don’t already have an iD, you’ll need to create one if you decide to submit a manuscript to International Journal of Technology Assessment in Health Care. You can register for one directly from your user account on Scholar One or via https://ORCID.org/register.

    If you already have an iD, please use this when submitting, either by linking it to your Scholar One account or supplying it during submission by using the “Associate your existing ORCID ID” button.


Last updated 7th September 2021